Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Altasciences Clinical Kansas Inc.
EIR
•Altasciences Clinical Kansas Inc.•September 19, 2017

Altasciences Clinical Kansas Inc. – FDA EIR, Sep 19, 2017

Record Details

An FDA inspection of Vince & Assoc Clinical Research, located in Overland Park, KS, was conducted from September 13 to September 19, 2017. This high-priority Bioresearch Monitoring (BIMO) inspection focused on a bioequivalence study involving investigational products PF-06438179 and Infliximab, under the regulatory framework of CP 7348.001. The inspection encompassed various aspects of clinical research operations, including chart audits, informed consent forms, source document verification against electronic Case Report Forms, drug reconciliation, and reserve sample collection. A significant outcome of this assessment was that no objectionable conditions or significant concerns were identified, and consequently, no FDA Form 483, Inspectional Observations, was issued to the firm. The report noted that a previous discussion item from a January 2017 inspection, regarding documentation improvements, had been successfully addressed. As part of the closing procedures, three reserve samples (595990, 595991, 595992) were collected. Management was reminded of its ongoing responsibility to adhere to regulatory compliance, and the potential consequences of non-adherence were discussed and acknowledged. The overall recommendation for this inspection was "No Action Indicated," reflecting the firm's satisfactory compliance with applicable regulations.

Company
Altasciences Clinical Kansas Inc.
Inspection date
September 19, 2017
Product type
biologics
Office
Kansas City District Office
People
  • Martin Kankam (company_representative)
  • Sharon B. Clark (company_representative)
  • Vickie J. Kanion (investigator)
  • Scott D. Smiley (company_representative)
  • Christopher D. Ore (recipient)
View Company Profile

ID · 9f8774fa-1c36-4897-aec3-bebd529dd0a8

Violation Codes1
21 CFR 820.100

Full citation text and observation details available on the Dashboard.

Other documents for Altasciences Clinical Kansas Inc.
  • EIR - 2017-06-07June 7, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Altasciences Clinical Kansas Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.